User talk:SemaglutideSasha

In Multi-dose vial the reference interval is given without the assay. Since the interval is method-dependent, stating it bare makes it look more universal than it is. Do you have the method from the source, or should the interval be attributed to the laboratory that published it? — FreightFenna (talk) 12:37, 25 August 2024 (UTC)

Good question, and I do not know. I have tagged it and asked on the article talk page. — SemaglutideSasha (talk) 22:47, 26 August 2024 (UTC)

The diagram you added to ChinaPeptides is much clearer than the paragraph it replaced, and it is correctly labelled, which is rarer than it should be. If you have the patience for more of them, Special:WantedPages is not the right list but the portals each keep a "things you can do" box, and several ask for figures. — SecondarySrc_Seb (talk) 10:06, 21 September 2024 (UTC)

Thank you. I will look at the portal boxes. — SemaglutideSasha (talk) 00:38, 22 September 2024 (UTC)

I have reworded one sentence in ChinaPeptides that read as an endorsement. The underlying fact is sourced and stayed; only the adjective went. See Project:Neutral point of view — the relevant part is that a number is almost always better than an adjective where one exists. — ReaderRosalie (talk) 23:52, 24 October 2024 (UTC)

No objection. Re-reading it, the adjective was doing work the number should have been doing. — SemaglutideSasha (talk) 06:10, 25 October 2024 (UTC)

Welcome to PeptidePedia Wiki. Two things worth reading early: Project:Verifiability, which is stricter here than on most wikis because of the subject matter, and Project:Manual of style, which settles the unit and spelling conventions so that articles can be read comparatively.

If a claim is worth making it is worth citing, and if a number is worth giving it is worth giving with its units and its source. Ask anything on the talk page of the article in question — that is where the reference-desk traffic goes. — RotationRosalind (talk) 01:38, 27 January 2025 (UTC)

I have reverted your recent change to Flourishglobal Peptide Biotech. The source cited does report the number, but it reports it for a different population than the sentence now claims. If I have misread the paper, please say so on the article talk page and I will restore it — I would rather be corrected than leave it wrong in either direction. — TallySheetTad (talk) 09:53, 23 March 2025 (UTC)

You read it correctly and I did not — the population is different. Thank you for catching it; I have struck my addition. — SemaglutideSasha (talk) 05:30, 24 March 2025 (UTC)

Just to say that ChinaPeptides is substantially better than it was a month ago. The table you added does the work that three paragraphs of prose were failing to do. — FigureFerdinand (talk) 11:05, 11 January 2026 (UTC)

Thank you, that is kind. The table was mostly a matter of noticing that three paragraphs were all trying to say the same thing. — SemaglutideSasha (talk) 09:45, 12 January 2026 (UTC)

Given your edits around Multi-dose vial, you might find the working-group pages useful — Project:Analytical working group, Project:Pharmacology working group and Project:Clinical evidence working group each keep a short priority list, and the priorities are mostly things one person can finish in an afternoon. — AnalyticalAnnie (talk) 10:59, 17 June 2026 (UTC)

Thank you, the priority lists are genuinely more useful than a general backlog. — SemaglutideSasha (talk) 17:58, 17 June 2026 (UTC)